(Q46798751)

25 December 2017

title

Anxiolytic and panicolytic effects of escitalopram in the elevated T-maze (English)

1 reference

25 December 2017

1 reference

Cristina Marta Del-Ben

2

1 reference

25 December 2017

author name string

S N Pinheiro

1

1 reference

25 December 2017

H Zangrossi

3

1 reference

25 December 2017

F G Graeff

4

1 reference

25 December 2017

language of work or name

English

0 references

publication date

21 January 2008

1 reference

25 December 2017

Journal of Psychopharmacology

published in

1 reference

25 December 2017

volume

22

1 reference

25 December 2017

issue

2

1 reference

25 December 2017

page(s)

132-137

1 reference

25 December 2017

Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881107079866

Effects of Hypericum perforatum and paroxetine on rat performance in the elevated T-maze

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107079866

Characterization of an allosteric citalopram-binding site at the serotonin transporter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107079866

Safety and efficacy of escitalopram in the long-term treatment of generalized anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107079866

Escitalopram in the treatment of generalized anxiety disorder: double-blind, placebo controlled, flexible-dose study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107079866

Effects of fluoxetine and buspirone on the panicolytic-like response induced by the activation of 5-HT1A and 5-HT2A receptors in the rat dorsal periaqueductal gray

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107079866

Effects of acute and long-term administration of escitalopram and citalopram on serotonin neurotransmission: an in vivo electrophysiological study in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107079866

Anxiolytic-Like Effects of Escitalopram, Citalopram, and R-Citalopram in Maternally Separated Mouse Pups

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107079866

Treatment of generalized anxiety disorder with escitalopram: pooled results from double-blind, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107079866

Serotonin, the periaqueductal gray and panic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107079866

The elevated T-maze as an experimental model of anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107079866

Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of ?fear?-motivated behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107079866

Prediction of anti-panic properties of escitalopram in the dorsal periaqueductal grey model of panic anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107079866

Chronic imipramine enhances 5-HT(1A) and 5-HT(2) receptors-mediated inhibition of panic-like behavior in the rat dorsal periaqueductal gray.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107079866

Effects of sibutramine on anxiety-related behaviours in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107079866

Escitalopram in the treatment of social anxiety disorder: randomised, placebo-controlled, flexible-dosage study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107079866

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107079866

Antipanic-like effect of serotonin reuptake inhibitors in the elevated T-maze

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107079866

R-citalopram attenuates anxiolytic effects of escitalopram in a rat ultrasonic vocalisation model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107079866

R-citalopram counteracts the effect of escitalopram in a rat conditioned fear stress model of anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107079866

Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107079866

Differential expression of Fos protein in the rat brain induced by performance of avoidance or escape in the elevated T-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107079866

Escitalopram for the treatment of GAD: efficacy across different subgroups and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107079866

Behavioral effects of acute and chronic imipramine in the elevated T-maze model of anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107079866

Escitalopram : a review of its use in the management of major depressive and anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107079866

Therapeutic potential of 5-HT2C receptor antagonists in the treatment of anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107079866

Behavioral validation of the elevated T-maze, a new animal model of anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107079866

Serotonergic regulation of inhibitory avoidance and one-way escape in the rat elevated T-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107079866

Chronic imipramine treatment sensitizes 5-HT1A and 5-HT 2 A receptors in the dorsal periaqueductal gray matter: evidence from the elevated T-maze test of anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107079866

Depression and antidepressant therapy: receptor dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107079866

21 January 2018

Identifiers

DOI

10.1177/0269881107079866

1 reference

25 December 2017

1 reference

25 December 2017